Literature DB >> 69040

Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing.

D W Trent.   

Abstract

Isoelectrofocusing of nonionic-detergent-disrupted flaviviruses separated the envelope glycoprotein of 53,000 to 58,000 daltons and the nucleocapsid protein of 14,000 daltons. The envelope protein and nucleocapsid protein were isolated at isoelectric points of pI 7.8 and 10.3, respectively. The antigenic determinants of St. Louis encephalitis, Japanese encephalitis, and dengue virus envelope and nucleocapsid proteins were examined by solid-phase competition radioimmunoassay. By the appropriate selection of antiserum and competing proteins, it was possible to distinguish type-specific, complex-reactive and flavivirus group-reactive antigenic determinants. The envelope glycoproteins of St. Louis encephalitis, Japanese encephalitis, and dengue viruses were found to contain each of these three classes of antigenic determinants. Most of the determinants on the envelope protein were type specific, some were complex reactive, and a small fraction were flavivirus group reactive. The nucleocapsid protein contained only flavivirus group-reactive antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69040      PMCID: PMC515759          DOI: 10.1128/JVI.22.3.608-618.1977

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  PROBLEMS OF TYPING DENGUE VIRUSES.

Authors:  W M HAMMONT; G E SATHER
Journal:  Mil Med       Date:  1964-02       Impact factor: 1.437

2.  RELATIONSHIPS AMONG ARTHROPOD-BORNE ANIMAL VIRUSES DETERMINED BY CROSS-CHALLENGE TESTS.

Authors:  J CASALS
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

3.  Immunological studies with group B arthropod-borne viruses. I. Broadened neutralizing antibody spectrum induced by strain 17D yellow fever vaccine in human subjects previously infected with Japanese encephalitis virus.

Authors:  C L WISSEMAN; B H SWEET; M KITAOKA; T TAMIYA
Journal:  Am J Trop Med Hyg       Date:  1962-07       Impact factor: 2.345

4.  Human gamma globulin fractionation on anion exchange cellulose columns.

Authors:  J L FAHEY; A P HORBETT
Journal:  J Biol Chem       Date:  1959-10       Impact factor: 5.157

5.  Viruses: the versatile parasites; the arthropod-borne group of animal viruses.

Authors:  J CASALS
Journal:  Trans N Y Acad Sci       Date:  1957-01

6.  Studies on the soluble antigen of influenza virus. I. The release of S antigen from elementary bodies by treatment with ether.

Authors:  W HENLE; F S LIEF
Journal:  Virology       Date:  1956-12       Impact factor: 3.616

7.  Isolation of the dengue virus envelope glycoprotein from membranes of infected cells by concanavalin A affinity chromatography.

Authors:  S A Stohlman; O R Eylar; C L Wisseman
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

8.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

9.  Antigenic analysis of certain group B arthropodborne viruses by antibody absorption.

Authors:  D H CLARKE
Journal:  J Exp Med       Date:  1960-01-01       Impact factor: 14.307

10.  ANTIGENIC VARIANTS OF EASTERN EQUINE ENCEPHALITIS VIRUS.

Authors:  J CASALS
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

View more
  17 in total

1.  Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies.

Authors:  J Kimura-Kuroda; K Yasui
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

2.  Immunological enhancement and the pathogenesis of dengue haemorrhagic fever.

Authors:  J S Porterfield
Journal:  J Hyg (Lond)       Date:  1982-12

3.  Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.

Authors:  A Yasuda; J Kimura-Kuroda; M Ogimoto; M Miyamoto; T Sata; T Sato; C Takamura; T Kurata; A Kojima; K Yasui
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 4.  The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.

Authors:  Beth-Ann G Coller; David E Clements; Andrew J Bett; Sangeetha L Sagar; Jan H Ter Meulen
Journal:  Vaccine       Date:  2011-07-21       Impact factor: 3.641

5.  Identification of Saint Louis encephalitis virus mRNA.

Authors:  C W Naeve; D W Trent
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

6.  Immunoglobulin G- and M-specific enzyme-linked immunosorbent assay for detection of dengue antibodies.

Authors:  D Dittmar; T J Cleary; A Castro
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

7.  Comparative study of infectious and formaldehyde-inactivated tick-borne encephalitis virus particles.

Authors:  I V Krasilnikov; L B Elbert; M K Khanina; S G Sobolev
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins.

Authors:  F X Heinz; W Tuma; C Kunz
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

9.  Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains.

Authors:  Nikos Vasilakis; Eric B Fokam; Christopher T Hanson; Ethan Weinberg; Amadou A Sall; Stephen S Whitehead; Kathryn A Hanley; Scott C Weaver
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

10.  Protease treatment and chemical crosslinking of a flavivirus: tick borne encephalitis virus.

Authors:  F X Heinz; C Kunz
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.